e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Epidemiology of various respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
E. Polverino, W. Cacheris, C. Spencer, E. Operschall, A.E. O‘Donnell (Barcelona, Spain; St. Louis, Washington, United States Of America; Berlin, Germany)
Source:
Annual Congress 2012 - Epidemiology of various respiratory diseases
Session:
Epidemiology of various respiratory diseases
Session type:
Thematic Poster Session
Number:
3983
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Polverino, W. Cacheris, C. Spencer, E. Operschall, A.E. O‘Donnell (Barcelona, Spain; St. Louis, Washington, United States Of America; Berlin, Germany). Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis. Eur Respir J 2012; 40: Suppl. 56, 3983
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Global impact of bronchiectasis and cystic fibrosis
Source: Breathe 2016; 12: 222-235
Year: 2016
Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Phenotype characterization of non-cystic fibrosis bronchiectasis in India.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Exacerbations in non cystic fibrosis bronchiectasis: clinical features and investigations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Quality of life in patients with non-cystic fibrosis bronchiectasis based on radiologic findings
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
Source: Eur Respir J 2014; 43: 1357-1367
Year: 2014
Physical activity evaluation in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Outcome of dedicated immune profiling in adult non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2007; 30: Suppl. 51, 529s
Year: 2007
Management and prevention of non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – PG9 Lower respiratory tract infection in children
Year: 2015
Changing characteristics of childhood non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Two-compartment model of gas mixing in patients with asthma and cystic fibrosis
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
Bronchiectasis: epidemiology and causes
Source: Eur Respir Mon 2011; 52: 1-10
Year: 2011
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept